Cleared Traditional

K993273 - N LATEX FERRITIN

K993273 is an FDA 510(k) clearance for N LATEX FERRITIN, manufactured by Dade Behring, Inc.. The device is a Class 2 Immunology device with product code DBF cleared through the Traditional 510(k) pathway after a 54-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
54d
Days
Class 2
Risk

K993273 is an FDA 510(k) clearance for the N LATEX FERRITIN. Classified as Ferritin, Antigen, Antiserum, Control (product code DBF), Class II - Special Controls.

Submitted by Dade Behring, Inc. (P.O. Box 6101, Newark, US). The FDA issued a Cleared decision on November 23, 1999 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5340 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dade Behring, Inc. devices

FDA 510(k) Submission Details - K993273

510(k) Number K993273 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 1999
Decision Date November 23, 1999
Days to Decision 54 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 105d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DBF Device Classification - Class 2, Special Controls

Product Code DBF Ferritin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBF Ferritin, Antigen, Antiserum, Control

All 73
Devices cleared under the same product code (DBF) and FDA review panel - the closest regulatory comparables to K993273.
OLYMPUS FERRITIN REAGENT
K030124 · Olympus America, Inc. · Feb 2003
K-ASSAY FERRITIN, K-ASSAY FERRITIN CALIBRATOR SET
K014293 · Kamiya Biomedical Co. · Feb 2002
RANDOX FERRITIN
K000662 · Randox Laboratories, Ltd. · Apr 2000
BIOCHECK FERRITIN ELISA MODEL BC-1025
K992517 · Biocheck, Inc. · Sep 1999
CHIRON DIAGNOSTICS ACS: 180 FERRITIN ASSAY
K992157 · Chiron Diagnostics Corp. · Aug 1999
NICHOLS ADVANTAGE CHEMILUMINESCENCE FERRITIN IMMUNOASSAY
K984186 · Nichols Institute Diagnostics · Feb 1999